Advancing New Antibacterial Drug Development for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia.
2016
The Clinical Trials Transformation Initiative (CTTI), a public-private partnership comprised of representatives from academia, the pharmaceutical industry, and the federal government including the US Food and Drug Administration, formed a group working toward a common goal of intensified research to facilitate the development of new antibacterial drug therapies for treatment of hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP). The summary of the CTTI HABP/VABP project in this supplement of Clinical Infectious Diseases is a first step in this direction.
Keywords:
- Public-Private Sector Partnership
- Alternative medicine
- Bacterial pneumonia
- General partnership
- Immunology
- Clinical trial
- Pharmaceutical industry
- Drug development
- Drug
- Medicine
- Government
- antibacterial drug
- food and drug administration
- Intensive care medicine
- Hospital-acquired pneumonia
- pneumonia ventilator associated
- Ventilator-associated pneumonia
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
3
References
3
Citations
NaN
KQI